AZENTA INC (AZTA) Fundamental Analysis & Valuation
NASDAQ:AZTA • US1143401024
Current stock price
20.45 USD
+0.26 (+1.29%)
At close:
20.45 USD
0 (0%)
After Hours:
This AZTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AZTA Profitability Analysis
1.1 Basic Checks
- AZTA had positive earnings in the past year.
- AZTA had a positive operating cash flow in the past year.
- In multiple years AZTA reported negative net income over the last 5 years.
- AZTA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- AZTA has a Return On Assets (-2.79%) which is in line with its industry peers.
- The Return On Equity of AZTA (-3.37%) is better than 60.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AZTA has a Gross Margin (44.59%) which is comparable to the rest of the industry.
- AZTA's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. AZTA Health Analysis
2.1 Basic Checks
- AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AZTA has been increased compared to 1 year ago.
- Compared to 5 years ago, AZTA has less shares outstanding
- Compared to 1 year ago, AZTA has an improved debt to assets ratio.
2.2 Solvency
- AZTA has an Altman-Z score of 3.06. This indicates that AZTA is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 3.06, AZTA is doing good in the industry, outperforming 66.07% of the companies in the same industry.
- There is no outstanding debt for AZTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.06 |
ROIC/WACCN/A
WACC10.93%
2.3 Liquidity
- AZTA has a Current Ratio of 2.92. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- AZTA's Current ratio of 2.92 is in line compared to the rest of the industry. AZTA outperforms 55.36% of its industry peers.
- AZTA has a Quick Ratio of 2.61. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- AZTA's Quick ratio of 2.61 is in line compared to the rest of the industry. AZTA outperforms 57.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 |
3. AZTA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 14.89% over the past year.
- Measured over the past years, AZTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.04% on average per year.
- Looking at the last year, AZTA shows a decrease in Revenue. The Revenue has decreased by -8.40% in the last year.
- AZTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.86% yearly.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
3.2 Future
- The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 5.37% on average over the next years.
EPS Next Y51.54%
EPS Next 2Y41.77%
EPS Next 3Y34.58%
EPS Next 5Y27.49%
Revenue Next Year4.92%
Revenue Next 2Y5.29%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. AZTA Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 37.87, the valuation of AZTA can be described as expensive.
- 62.50% of the companies in the same industry are more expensive than AZTA, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 25.54, AZTA is valued a bit more expensive.
- The Price/Forward Earnings ratio is 19.20, which indicates a rather expensive current valuation of AZTA.
- 80.36% of the companies in the same industry are more expensive than AZTA, based on the Price/Forward Earnings ratio.
- AZTA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.87 | ||
| Fwd PE | 19.2 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AZTA is valued cheaper than 92.86% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, AZTA is valued a bit cheaper than the industry average as 69.64% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.45 | ||
| EV/EBITDA | 11.21 |
4.3 Compensation for Growth
- AZTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- AZTA's earnings are expected to grow with 34.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y41.77%
EPS Next 3Y34.58%
5. AZTA Dividend Analysis
5.1 Amount
- No dividends for AZTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AZTA Fundamentals: All Metrics, Ratios and Statistics
20.45
+0.26 (+1.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/amc
Inst Owners115.54%
Inst Owner ChangeN/A
Ins Owners0.69%
Ins Owner Change12.39%
Market Cap941.93M
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Analysts77.14
Price Target38.47 (88.12%)
Short Float %10.24%
Short Ratio5.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-35.95%
Max EPS beat(2)8.65%
EPS beat(4)2
Avg EPS beat(4)-5.26%
Min EPS beat(4)-35.95%
Max EPS beat(4)36.22%
EPS beat(8)6
Avg EPS beat(8)46.66%
EPS beat(12)9
Avg EPS beat(12)140.12%
EPS beat(16)13
Avg EPS beat(16)118.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-1.08%
PT rev (1m)-4.35%
PT rev (3m)-2.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.75%
EPS NY rev (1m)0.28%
EPS NY rev (3m)0.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.87 | ||
| Fwd PE | 19.2 | ||
| P/S | 1.58 | ||
| P/FCF | 30.45 | ||
| P/OCF | 15.1 | ||
| P/B | 0.55 | ||
| P/tB | 1.03 | ||
| EV/EBITDA | 11.21 |
EPS(TTM)0.54
EY2.64%
EPS(NY)1.07
Fwd EY5.21%
FCF(TTM)0.67
FCFY3.28%
OCF(TTM)1.35
OCFY6.62%
SpS12.92
BVpS37.23
TBVpS19.88
PEG (NY)0.73
PEG (5Y)N/A
Graham Number21.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% | ||
| FCFM | 5.2% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 55.45% | ||
| Cap/Sales | 5.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 156.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 | ||
| Altman-Z | 3.06 |
F-Score5
WACC10.93%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y51.54%
EPS Next 2Y41.77%
EPS Next 3Y34.58%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year4.92%
Revenue Next 2Y5.29%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
EBIT growth 1Y71.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year495.06%
EBIT Next 3Y107.17%
EBIT Next 5YN/A
FCF growth 1Y-4.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.01%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 5 / 10 to AZTA.
What is the valuation status of AZENTA INC (AZTA) stock?
ChartMill assigns a valuation rating of 5 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.
How profitable is AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a profitability rating of 3 / 10.
Can you provide the financial health for AZTA stock?
The financial health rating of AZENTA INC (AZTA) is 8 / 10.
How sustainable is the dividend of AZENTA INC (AZTA) stock?
The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.